Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Here, tofacitinib safety and efficacy data from a long-term extension study in Japanese patients are presented. METHODS: Study A3921041 was a multi-centre, open-label, long-term extension study that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Yamanaka, Hisashi, Tanaka, Yoshiya, Takeuchi, Tsutomu, Sugiyama, Naonobu, Yuasa, Hirotoshi, Toyoizumi, Shigeyuki, Morishima, Yosuke, Hirose, Tomohiro, Zwillich, Samuel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4730592/
https://ncbi.nlm.nih.gov/pubmed/26818974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0932-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados